Article Versions Notes

Liu Y, Li Y, Xu P, Shen Y, Tang B, Wang Q. Development of Abiraterone Acetate Nanocrystal Tablets to Enhance Oral Bioavailability: Formulation Optimization, Characterization, In Vitro Dissolution and Pharmacokinetic Evaluation. Pharmaceutics. 2022; 14(6):1134. https://doi.org/10.3390/pharmaceutics14061134

Liu, Yuanfen, Yuqi Li, Pengcheng Xu, Yan Shen, Baoqiang Tang, and Qiyue Wang. 2022. "Development of Abiraterone Acetate Nanocrystal Tablets to Enhance Oral Bioavailability: Formulation Optimization, Characterization, In Vitro Dissolution and Pharmacokinetic Evaluation" Pharmaceutics 14, no. 6: 1134. https://doi.org/10.3390/pharmaceutics14061134

Liu, Y., Li, Y., Xu, P., Shen, Y., Tang, B., & Wang, Q. (2022). Development of Abiraterone Acetate Nanocrystal Tablets to Enhance Oral Bioavailability: Formulation Optimization, Characterization, In Vitro Dissolution and Pharmacokinetic Evaluation. Pharmaceutics, 14(6), 1134. https://doi.org/10.3390/pharmaceutics14061134